The question really is whether Exopharm's LEAP technique for purification of exosomes offers a more efficacious way to isolate exosomes at scale and whether Codiak's technique may contain any steps that are covered under Exosome's latest patent. GLTAH R-7
EX1 Price at posting:
40.0¢ Sentiment: None Disclosure: Held
